The Winship Cancer Institute of Emory University (Winship) planning and evaluation process, overseen by the Executive Director, Walter J. Curran, Jr., MD, is responsible for the systematic planning and evaluation of Winship, its research programs, shared resources, clinical research enterprise, and clinical operations. Winship relies on the input of expert internal and external consultants and leaders to plan and evaluate its strategic research priorities and for the assessment of the progress of research programs, impact of shared resources, administrative support, and organizational structure. These activities are directed internally by the Winship Internal Advisory Board and the Winship Executive Committee. An External Advisory Board (EAB) is composed of a renowned group of cancer center directors, program leaders, researchers, and administrators from other NCI-designated cancer centers across the country. The EAB is charged to provide critical evaluation of Winship's activities and strategic plan. During the current funding period, input from each of the boards and committees discussed in this section Winship to improve processes and elevate the level of its science. Thorough planning and evaluation has led to the development of the Winship 2016 ? 2018 Strategic Plan. The plan will guide the centers continued develoment during the next funding cycle. The funds requested in addition to committed institutional funds will provide support for these important advisory endeavors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA138292-12
Application #
9905354
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
12
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5
Bekhbat, Mandakh; Chu, Karen; Le, Ngoc-Anh et al. (2018) Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology 98:222-229
Felger, Jennifer C; Haroon, Ebrahim; Patel, Trusharth A et al. (2018) What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry :
Akce, Mehmet; Zaidi, Mohammad Y; Waller, Edmund K et al. (2018) The Potential of CAR T Cell Therapy in Pancreatic Cancer. Front Immunol 9:2166
Greenwell, I Brian; Staton, Ashley D; Lee, Michael J et al. (2018) Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Cancer 124:2306-2315
Hou, Yue; Konen, Jessica; Brat, Daniel J et al. (2018) TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics. Sci Rep 8:7248
Sadigh, Gelareh; Duszak Jr, Richard; Ward, Kevin C et al. (2018) Downstream Breast Imaging Following Screening Mammography in Medicare Patients with Advanced Cancer: A Population-Based Study. J Gen Intern Med 33:284-290
Patel, Mihir R; Hudgins, Patricia A; Beitler, Jonathan J et al. (2018) Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer. ORL J Otorhinolaryngol Relat Spec 80:85-95
Goldstein, Jordan S; Nastoupil, Loretta J; Han, Xuesong et al. (2018) Disparities in survival by insurance status in follicular lymphoma. Blood 132:1159-1166
Richardson, Alessandra M; Havel, Lauren S; Koyen, Allyson E et al. (2018) Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion. Clin Cancer Res 24:420-432

Showing the most recent 10 out of 331 publications